The regulation of CD73 in non-small cell lung cancer
- 19 May 2022
- journal article
- research article
- Published by Elsevier in European Journal of Cancer
- Vol. 170, 91-102
Abstract
No abstract availableKeywords
Funding Information
- AstraZeneca plc
This publication has 42 references indexed in Scilit:
- CD73 promotes tumor growth and metastasisOncoImmunology, 2012
- Anti-CD73 antibody therapy inhibits breast tumor growth and metastasisProceedings of the National Academy of Sciences, 2010
- Frequency and Distinctive Spectrum of KRAS Mutations in Never Smokers with Lung AdenocarcinomaClinical Cancer Research, 2008
- Identification of the transforming EML4–ALK fusion gene in non-small-cell lung cancerNature, 2007
- Ecto-5′-Nucleotidase (eN, CD73) is Coexpressed with Metastasis Promoting Antigens in Human Melanoma CellsNucleosides, Nucleotides & Nucleic Acids, 2006
- Adenosine receptors as therapeutic targetsNature Reviews Drug Discovery, 2006
- Wnt and β-catenin signaling target the expression of ecto-5′-nucleotidase and increase extracellular adenosine generationExperimental Cell Research, 2004
- Molecular Approach to Adenosine Receptors: Receptor-Mediated Mechanisms of Tissue ProtectionAnnual Review of Pharmacology and Toxicology, 2001
- NUCLEOSIDE-PHOSPHORYLASE DEFICIENCY IN A CHILD WITH SEVERELY DEFECTIVE T-CELL IMMUNITY AND NORMAL B-CELL IMMUNITYThe Lancet, 1975
- ADENOSINE-DEAMINASE DEFICIENCY IN TWO PATIENTS WITH SEVERELY IMPAIRED CELLULAR IMMUNITYThe Lancet, 1972